Therapeutic drug management

Therapeutic drug management (TDM) of most antidepressants is not widely available or widely utilized, for any clinical indication. The primary benefits of TDM in the management of antidepressant therapy could include assessment of patient compliance, detection of drug-drug interactions or altered pharmacokinetics, and evaluating the concentration relationship of individual patient response and/or thresholds for dose-related side effects. Of all the classes of antidepressant drugs, TDM of TCAs is most common. 

The existence of a Ps-adrenoceptor has recently been demonstrated in human adipose tissue along with the Pi-adrenoceptor. This observation raises the possibility that eventually therapeutic drugs may selectively alter Upid metabolism and therefore provide therapeutic management of obesity. The Ps-receptor and the recently identified subtypes within the aj- and az-receptor groups ( iA, ttiB, etc.) also have not been included in the... 

The approval of genetically engineered version of human DNAase, which breaks down protein accumulation in the lungs of CF patients. It was the first new therapeutic drug for the management of cystic fibrosis in over 30 years... 

HPLC is an indispensable tool in the laboratory Therapeutic drug monitoring Monitoring of asthma treatment Management of epilepsy treatment A qualitative analysis tool J Testing incoming raw materials... 

Therapeutic Drugs and Their Management Therapeutic Drugs and Their Management Appendix Toxic Metals Toxic Metals Appendix... 

---